FITC Anti-Human CD44 Antibody[Hermes-1]

FITC Anti-Human CD44 Antibody[Hermes-1]

The FITC Anti-Human CD44 Antibody [HERMES-1] is a monoclonal antibody that is designed to specifically target the CD44 antigen in human cells. This antibody is conjugated with fluorescein isothiocyanate (FITC), which allows for easy detection and visualization of the CD44 antigen in flow cytometry and immunofluorescence assays. The HERMES-1 clone of this antibody has been extensively validated and is widely used in research and diagnostic applications.

CD44 is a transmembrane glycoprotein that is expressed on the surface of a variety of cells, including leukocytes, epithelial cells, and stem cells. It plays a critical role in cell adhesion, migration, and signaling, and is involved in a wide range of physiological and pathological processes, such as inflammation, wound healing, cancer metastasis, and stem cell differentiation. The FITC Anti-Human CD44 Antibody [HERMES-1] is a valuable tool for studying the expression and function of CD44 in different cell types and tissues, and for identifying and characterizing CD44-positive cells in complex biological samples.

The FITC Anti-Human CD44 Antibody [HERMES-1] is supplied as a purified, sterile, and concentrated solution that is ready to use in various applications. It has been optimized for use in flow cytometry and immunofluorescence assays, and can be used for both qualitative and quantitative analysis of CD44 expression. This antibody is highly specific and sensitive, and has low background staining, which ensures accurate and reliable results. It is suitable for use with a wide range of human samples, including blood, bone marrow, lymph nodes, and solid tissues. Overall, the FITC Anti-Human CD44 Antibody [HERMES-1] is a high-quality reagent that can help researchers and clinicians advance their understanding of CD44 biology and its role in human health and disease.